XML 39 R28.htm IDEA: XBRL DOCUMENT v3.21.1

Collaboration, Licensing and Other Arrangements (Tables)

3 Months Ended

Mar. 31, 2021

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Schedule of Revenue from Collaboration and Services

Revenue from collaborations and services for the three months ended March 31, 2021 and 2020 are as follows (in thousands):

		Three Months Ended March 31,
		2021				2020
UT License Agreement		$	8,999			$	7,978
Vertice Pharma Co-promotion Agreement			292				—
Receptor CLA			10				62
Cipla License and Distribution Agreement			36				37
UT Research Agreement			—				158
Total revenue from collaborations and services		$	9,337			$	8,235

X

- References

No definition available.

+ Details

Name:	us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 808
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434

+ Details

Name:	us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration